Activation and detoxification of bromobenzene in extrahepatic tissues

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Bromobenzene causes hepatic and extrahepatic toxicity in rats. Toxicity is related to the presence of covalently bound material in these tissues. A major bromobenzene metabolite, p-bromophenol, has been shown to give rise to covalently bound material in liver, lung and kidney in vivo, but is not toxic. p-Bromophenol is formed from bromobenzene in liver, lung and kidney microsomes and is subsequently metabolized to 4-bromocatechol and covalently bound material. Bromobenzene-3, 4-oxide generated in situ by liver microsomes, is detoxified by kidney, liver and lung cytosol. The results suggest that the kidney toxicity caused by bromobenzene is probably not mediated by either bromobenzene-3, 4-oxide or the reactive metabolites of p-bromophenol. In contrast, bromobenzene-3, 4-oxide may play a role in the lung toxicity observed after bromobenzene administration. However, the covalently bound material found in extrahepatic tissues may be derived from both bromobenzene-3, 4-oxide or the reactive metabolites of p-bromophenol, which may be formed directly by these tissues or transported there from the liver.

Original languageEnglish (US)
Pages (from-to)561-568
Number of pages8
JournalLife Sciences
Volume35
Issue number5
DOIs
StatePublished - Jul 30 1984
Externally publishedYes

Fingerprint

Detoxification
Liver
Chemical activation
Toxicity
Tissue
Metabolites
Kidney
Lung
Poisons
Liver Microsomes
Microsomes
Cytosol
Rats
bromobenzene
bromobenzene 3,4-oxide
4-bromophenol

ASJC Scopus subject areas

  • Pharmacology

Cite this

Activation and detoxification of bromobenzene in extrahepatic tissues. / Monks, Terrence; Lau, Serrine.

In: Life Sciences, Vol. 35, No. 5, 30.07.1984, p. 561-568.

Research output: Contribution to journalArticle

@article{262c0a0e50ed41beb1c9331445e05f94,
title = "Activation and detoxification of bromobenzene in extrahepatic tissues",
abstract = "Bromobenzene causes hepatic and extrahepatic toxicity in rats. Toxicity is related to the presence of covalently bound material in these tissues. A major bromobenzene metabolite, p-bromophenol, has been shown to give rise to covalently bound material in liver, lung and kidney in vivo, but is not toxic. p-Bromophenol is formed from bromobenzene in liver, lung and kidney microsomes and is subsequently metabolized to 4-bromocatechol and covalently bound material. Bromobenzene-3, 4-oxide generated in situ by liver microsomes, is detoxified by kidney, liver and lung cytosol. The results suggest that the kidney toxicity caused by bromobenzene is probably not mediated by either bromobenzene-3, 4-oxide or the reactive metabolites of p-bromophenol. In contrast, bromobenzene-3, 4-oxide may play a role in the lung toxicity observed after bromobenzene administration. However, the covalently bound material found in extrahepatic tissues may be derived from both bromobenzene-3, 4-oxide or the reactive metabolites of p-bromophenol, which may be formed directly by these tissues or transported there from the liver.",
author = "Terrence Monks and Serrine Lau",
year = "1984",
month = "7",
day = "30",
doi = "10.1016/0024-3205(84)90250-9",
language = "English (US)",
volume = "35",
pages = "561--568",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Activation and detoxification of bromobenzene in extrahepatic tissues

AU - Monks, Terrence

AU - Lau, Serrine

PY - 1984/7/30

Y1 - 1984/7/30

N2 - Bromobenzene causes hepatic and extrahepatic toxicity in rats. Toxicity is related to the presence of covalently bound material in these tissues. A major bromobenzene metabolite, p-bromophenol, has been shown to give rise to covalently bound material in liver, lung and kidney in vivo, but is not toxic. p-Bromophenol is formed from bromobenzene in liver, lung and kidney microsomes and is subsequently metabolized to 4-bromocatechol and covalently bound material. Bromobenzene-3, 4-oxide generated in situ by liver microsomes, is detoxified by kidney, liver and lung cytosol. The results suggest that the kidney toxicity caused by bromobenzene is probably not mediated by either bromobenzene-3, 4-oxide or the reactive metabolites of p-bromophenol. In contrast, bromobenzene-3, 4-oxide may play a role in the lung toxicity observed after bromobenzene administration. However, the covalently bound material found in extrahepatic tissues may be derived from both bromobenzene-3, 4-oxide or the reactive metabolites of p-bromophenol, which may be formed directly by these tissues or transported there from the liver.

AB - Bromobenzene causes hepatic and extrahepatic toxicity in rats. Toxicity is related to the presence of covalently bound material in these tissues. A major bromobenzene metabolite, p-bromophenol, has been shown to give rise to covalently bound material in liver, lung and kidney in vivo, but is not toxic. p-Bromophenol is formed from bromobenzene in liver, lung and kidney microsomes and is subsequently metabolized to 4-bromocatechol and covalently bound material. Bromobenzene-3, 4-oxide generated in situ by liver microsomes, is detoxified by kidney, liver and lung cytosol. The results suggest that the kidney toxicity caused by bromobenzene is probably not mediated by either bromobenzene-3, 4-oxide or the reactive metabolites of p-bromophenol. In contrast, bromobenzene-3, 4-oxide may play a role in the lung toxicity observed after bromobenzene administration. However, the covalently bound material found in extrahepatic tissues may be derived from both bromobenzene-3, 4-oxide or the reactive metabolites of p-bromophenol, which may be formed directly by these tissues or transported there from the liver.

UR - http://www.scopus.com/inward/record.url?scp=0021261593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021261593&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(84)90250-9

DO - 10.1016/0024-3205(84)90250-9

M3 - Article

C2 - 6748863

AN - SCOPUS:0021261593

VL - 35

SP - 561

EP - 568

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 5

ER -